Study on collateral sensitivity of tigecycline to colistin-resistant Enterobacter cloacae complex
Microbiology Spectrum · 2025
DOI: 10.1128/spectrum.03310-24 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microbiology Spectrum, 2025. Verfasst von Kaixin Yu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Yongchuan Hospital of Chongqing Medical University, Chongqing, China. Hauptthemen laut MEDLINE: Tigecycline, Colistin, Enterobacter cloacae, Anti-Bacterial Agents. Die Arbeit nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The past decade has witnessed the emergence and spread of carbapenem-resistant Enterobacter cloacae complex (CRECC), presenting a significant clinical challenge and urgently demanding new treatment strategies against antimicrobial resistance (AMR). This study focused on the impact of tigecycline on the susceptibility of CRECC isolates to colistin and the collateral sensitivity in CRECC. Under tigecycline pressure, the resistance of five clinically isolated CRECC strains to colistin was converted from resistance to sensitivity. These mutants exhibited significantly higher expression of acrA, acrB , and ramA genes, with mutations in the ramR gene. Overexpression of ramA in certain mutants did not alter ramR expression. No mutations were identified in lipid A synthesis genes; however, phoQ was consistently downregulated, and arnA expression varied among CRECC405-resistant mutants. Low-dose colistin and tigecycline combination therapy outperformed monotherapy in antimicrobial efficacy. Overall, collateral susceptibility to tigecycline was observed in CRECC isolates with colistin resistance. The overexpression of acrA, acrB, and ramA , due to ramR mutations, led to tigecycline resistance. Inconsistent expression levels of lipid A synthesis genes affected lipid A modification, which in turn upregulated arnA expression in CRECC405-resistant mutants. Increased sensitivity to colistin was associated with the downregulation of phoQ and arnA expression. IMPORTANCE Antimicrobial resistance (AMR) is escalating faster than our ability to manage bacterial infections, with antibiotic-resistant bacteria emerging as a significant public health risk. Innovative strategies are urgently needed to curb AMR dissemination. Our research identified collateral sensitivity in Enterobacter cloacae complex following tigecycline (TGC) resistance, resulting in newfound sensitivity to colistin (COL), a drug to which it was once resistant. Synergistic tigecycline and colistin therapy significantly suppress bacterial growth, offering a promising approach to combat infections and curb AMR progression through the strategic pairing of antibiotics with complementary sensitivities.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbiology, Yongchuan Hospital of Chongqing Medical University, Chongqing, China.
- Department of Pathogenic Biology, Basic Medicine of Jiamusi University, Jiamusi, China.
- Department of Life Science and Technology, Mudanjiang Normal University, Mudanjiang, China.
ORCID-Profile: Kaixin Yu, Chunjiang Li, Xiaoli Zhang
Zitieren
APA
Yu, K., Wu, J., Liao, M., Wang, J., Wei, C., Long, W., Gou, X., Yang, Y., Wang, J., Liang, X., Li, C., & Zhang, X. (2025). Study on collateral sensitivity of tigecycline to colistin-resistant Enterobacter cloacae complex. Microbiology Spectrum. https://doi.org/10.1128/spectrum.03310-24
Vancouver
Yu K, Wu J, Liao M, Wang J, Wei C, Long W, et al. Study on collateral sensitivity of tigecycline to colistin-resistant Enterobacter cloacae complex. Microbiology Spectrum. 2025. doi:10.1128/spectrum.03310-24
BibTeX
@article{Yu2025,
author = {Yu, Kaixin and Wu, Jiming and Liao, Mingjing and Wang, Jianmin and Wei, Chunli and Long, Wenzhang and Gou, Xuemei and Yang, Yang and Wang, Jin and Liang, Xushan and Li, Chunjiang and Zhang, Xiaoli},
title = {Study on collateral sensitivity of tigecycline to colistin-resistant Enterobacter cloacae complex},
journal = {Microbiology Spectrum},
year = {2025},
doi = {10.1128/spectrum.03310-24}
}
EUVIMED